HSV-1 is extremely common. In the United States, about 48% of people aged 14 to 49 have it, based on CDC data from 2015–2016. Among adults broadly, the rate climbs to roughly 64%. Globally, the majority of people will contract HSV-1 at some point in their lives, and most never realize it.
How Common HSV-1 Is by Age
HSV-1 prevalence rises steadily with age. Among children in the general population, about 38% already carry the virus. By adulthood, that figure jumps to around 64%. Age alone accounts for 43% of the variation in infection rates, meaning the longer you’ve been alive, the more likely you are to have been exposed.
Historically, most people picked up HSV-1 during childhood through nonsexual contact: a kiss from a parent or relative, shared utensils, or simply being around other kids. That pattern is shifting. Fewer children are acquiring the virus orally, which means more young adults encounter it for the first time through sexual contact, sometimes resulting in genital rather than oral infection.
Most People Never Get Symptoms
The majority of people with HSV-1 have no symptoms or such mild ones that they never notice. They carry the virus without ever developing a cold sore. This is the main reason it spreads so easily: people pass it along without knowing they have it.
When symptoms do appear, they typically show up as small, painful blisters or ulcers around the mouth (cold sores) or, less commonly, on the genitals. These outbreaks can recur, but they tend to become less frequent over time. Many people experience one initial outbreak and then nothing for years, or ever again.
Spreading Without Symptoms
HSV-1 can spread even when no sores are visible. The virus periodically becomes active on the skin’s surface without causing noticeable symptoms, a process called asymptomatic shedding. A study published in JAMA tracked people with genital HSV-1 and found that the virus was detectable on about 12% of days in the first few months after infection. By one year out, shedding dropped to about 7% of days, with truly symptom-free shedding occurring on roughly 5% of days.
Oral HSV-1 follows a similar pattern. The virus can be present in saliva on days when a person feels perfectly fine and has no visible sores. This is why HSV-1 is so widespread: transmission doesn’t require an active outbreak.
HSV-1 as a Cause of Genital Herpes
HSV-1 is no longer just “oral herpes.” It now causes a significant share of genital herpes cases, largely through oral sex. Research tracking trends over a six-year period found that by 1999, about 42% of all genital herpes cases were caused by HSV-1 rather than HSV-2. Among women, the proportion was even higher at nearly 45%. These numbers have likely continued rising as fewer young people carry oral HSV-1 from childhood, leaving them vulnerable to genital acquisition later.
Genital HSV-1 tends to behave differently from genital HSV-2. Outbreaks are typically less frequent, and viral shedding decreases more over time. But the initial episode can be just as uncomfortable, and the virus can still be transmitted to partners.
When HSV-1 Poses Serious Risks
For most healthy adults, HSV-1 is a manageable nuisance at worst. Serious complications are rare but do exist in specific situations.
The highest-risk scenario involves newborns. Neonatal herpes occurs in roughly 1 in 1,700 to 1 in 8,200 live births in the U.S. The risk is greatest when a mother acquires a new genital herpes infection (either type) during pregnancy, where transmission rates range from 25% to 50%. By contrast, women with longstanding infections who happen to shed virus at delivery transmit it less than 1% of the time. Neonatal herpes is serious: without treatment, survival drops to 40%, and even with antiviral treatment, disseminated disease carries a 30% mortality rate.
In adults with weakened immune systems, HSV-1 can cause more severe or prolonged outbreaks and, in rare cases, complications like encephalitis (infection of the brain).
Testing and What It Tells You
Blood tests for HSV-1 look for antibodies your immune system produces in response to infection. These antibodies don’t reliably appear until at least two weeks after exposure, so testing too early can miss a recent infection. The tests themselves vary in accuracy: sensitivity ranges from 69% to 99%, and specificity from 77% to 98%, depending on the specific test used.
This variability is one reason routine HSV-1 screening isn’t standard practice. A positive result tells you that you’ve been infected at some point, but it can’t tell you when you got the virus or where on your body it lives. Given that nearly half the adult population would test positive, a result without symptoms often raises more questions than it answers. Swab testing during an active outbreak is far more useful for confirming whether a specific sore is caused by herpes and identifying the type.